Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study

2020 ◽  
Vol 7 (12) ◽  
pp. e861-e873 ◽  
Author(s):  
Paola Tacchetti ◽  
Lucia Pantani ◽  
Francesca Patriarca ◽  
Maria Teresa Petrucci ◽  
Elena Zamagni ◽  
...  
Keyword(s):  
Haematopoietic Stem Cell Transplantation ◽  
Haematopoietic Stem Cell ◽  
Newly Diagnosed ◽  
Open Label ◽  
Phase 3 ◽  
Open Label Study ◽  
Label Study ◽  
Long Term Follow Up

scholarly journals Long-term follow-up of DYT1 dystonia patients treated by deep brain stimulation: An open-label study

2010 ◽  
Vol 25 (3) ◽  
pp. 289-299 ◽  
Author(s):  
Laura Cif ◽  
Xavier Vasques ◽  
Victoria Gonzalez ◽  
Patrice Ravel ◽  
Brigitte Biolsi ◽  
...  
Keyword(s):  
Deep Brain Stimulation ◽  
Brain Stimulation ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Dyt1 Dystonia ◽  
Long Term Follow Up ◽  
Deep Brain

scholarly journals Rituximab in refractory myasthenia gravis: a prospective, open‐label study with long‐term follow‐up

2016 ◽  
Vol 3 (7) ◽  
pp. 552-555 ◽  
Author(s):  
Dustin Anderson ◽  
Cecile Phan ◽  
Wendy S. Johnston ◽  
Zaeem A. Siddiqi
Keyword(s):  
Myasthenia Gravis ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Long Term Follow Up

scholarly journals Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long‐term follow‐up of the randomized, open‐label, phase 3 CheckMate 025 trial

Cancer ◽  
2020 ◽  
Vol 126 (18) ◽  
pp. 4156-4167 ◽  
Author(s):  
Robert J. Motzer ◽  
Bernard Escudier ◽  
Saby George ◽  
Hans J. Hammers ◽  
Sandhya Srinivas ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Advanced Renal Cell Carcinoma ◽  
Open Label ◽  
Phase 3 ◽  
Open Label Phase ◽  
Long Term Follow Up

scholarly journals Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study

2014 ◽  
Vol 15 (3) ◽  
pp. 323-332 ◽  
Author(s):  
Grant A McArthur ◽  
Paul B Chapman ◽  
Caroline Robert ◽  
James Larkin ◽  
John B Haanen ◽  
...  
Keyword(s):  
Open Label ◽  
Phase 3 ◽  
Open Label Study ◽  
Label Study ◽  
Safety And Efficacy
Sign in / Sign up

Export Citation Format

Share Document